Growth Metrics

Nexalin Technology (NXL) Profit After Tax Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 -5.46%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.46%
Dec 31, 2025 16.12%
Sep 30, 2025 7.02%
Jun 30, 2025 -23.08%
Mar 31, 2025 -90.97%
Dec 31, 2024 -262.93%
Sep 30, 2024 -6.58%
Jun 30, 2024 -56.18%
Mar 31, 2024 -39.12%
Dec 31, 2023 -6.99%
Sep 30, 2023 -1,596.58%
Jun 30, 2023 -77.86%
Mar 31, 2023 -90.32%
Dec 31, 2022 -22.44%
Sep 30, 2022 92.48%